LRFN1

LRFN1 (SALM1) is a brain-enriched transmembrane glycoprotein with an extracellular LRR-Ig-Fn domain architecture whose C-terminal PDZ-binding motif directly engages the postsynaptic scaffold PSD-95 and whose intracellular domain selectively interacts with NMDA receptors but not AMPA receptors (PMID:16828986, PMID:21736948). The extracellular LRR and Ig domains mediate a 2:2 trans-synaptic complex with presynaptic receptor-type tyrosine phosphatase PTPδ, as demonstrated by crystal structure analysis, positioning LRFN1 as a synaptic organizer bridging pre- and postsynaptic compartments (PMID:29348429). Both the C-terminal PDZ-binding domain and the N-terminal extracellular domains are required for LRFN1-driven neurite outgrowth in hippocampal neurons, and LRFN1 forms homo- and heteromeric cis-complexes with other SALM family members (PMID:18585462, PMID:21736948).

1. 2006 Medium

   Identifying LRFN1 as a neuronal transmembrane glycoprotein that directly binds PSD-95 via its C-terminal PDZ-binding motif established the first molecular link between the SALM family and postsynaptic scaffolding.

   Evidence Co-expression/redistribution assay and PDZ domain binding assay in heterologous cells

   PMID:16828986

   Open questions at the time

   • Interaction demonstrated in overexpression system, not confirmed at endogenous levels in neurons
   • Functional consequence of PSD-95 binding at synapses not tested
   • Extracellular ligand unknown
2. 2008 Medium

   Demonstrating that LRFN1 promotes neurite outgrowth through both its PDZ-binding C-terminus and its extracellular N-terminus resolved that synapse-organizing SALMs also regulate neuronal morphogenesis through separable domains.

   Evidence Overexpression of deletion/chimeric constructs, RNAi knockdown, and antibody blocking in cultured hippocampal neurons

   PMID:18585462

   Open questions at the time

   • In vivo validation of neurite outgrowth phenotype lacking
   • Specific extracellular binding partner mediating outgrowth not identified
   • Relative contribution of LRFN1 versus other SALMs in outgrowth not separated
3. 2011 Medium

   Establishing that LRFN1 selectively interacts with NMDA receptors (not AMPA receptors) and forms homo- and heteromeric cis-complexes with other SALMs revealed a combinatorial logic for postsynaptic receptor organization.

   Evidence Co-immunoprecipitation and complex formation assays

   PMID:21736948

   Open questions at the time

   • NMDA receptor interaction based on co-IP; direct binding domain not mapped
   • Functional impact on NMDA receptor trafficking or gating not tested
   • Stoichiometry of SALM cis-complexes undefined
4. 2018 High

   Solving the crystal structure of the PTPδ–SALM complex at atomic resolution established the structural basis for a 2:2 trans-synaptic bridging mechanism mediated by the LRR and Ig domains, explaining how LRFN1 organizes synaptic contacts.

   Evidence X-ray crystallography of PTPδ-SALM2 complex with site-directed mutagenesis and synaptogenic co-culture validation

   PMID:29348429

   Open questions at the time

   • Crystal structure solved for SALM2 (LRFN4); direct structural data for LRFN1–PTPδ complex not yet available
   • In vivo relevance of PTPδ interaction for LRFN1-specific synaptogenesis not demonstrated
   • Whether other LAR-RPTP family members bind LRFN1 comparably is untested
5. 2022 Medium

   Identifying miR-187-3p as a direct post-transcriptional repressor of LRFN1 via its 3′-UTR extended LRFN1 regulation beyond synaptic biology into a cancer-relevant context.

   Evidence Luciferase reporter assay, miRNA mimic transfection, rescue experiments in ccRCC cell lines and xenograft models

   PMID:35799072

   Open questions at the time

   • Mechanism by which LRFN1 promotes proliferation/invasion in non-neuronal cells is unknown
   • Relevance of miR-187-3p regulation to LRFN1 function in the brain not addressed
   • Single-lab finding in cancer context without independent replication

• The in vivo synaptic phenotype of LRFN1 loss-of-function and the precise mechanism by which LRFN1 coordinates NMDA receptor function, PSD-95 scaffolding, and PTPδ trans-synaptic signaling remain unresolved.
• No Lrfn1 knockout mouse phenotype reported
• No electrophysiological characterization of LRFN1-dependent synaptic transmission
• Structural basis for LRFN1-specific (versus other SALM) functions not determined